Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS)

Contact Dermatitis

Volumn 62, Issue 1, 2010, Pages 47-53

  Santiago, Felicidade ^a   Gonçalo, Margarida ^a   Vieira, Ricardo ^a   Coelho, Sónia ^b   Figueiredo, Américo ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b Hospital Infante D Pedro EPE   (Portugal)

Author keywords

Allopurinol; Antiepileptics; Carbamazepine; DRESS; Lamotrigine; Patch testing

Indexed keywords

ALLOPURINOL; AMOXICILLIN; ANTICONVULSIVE AGENT; CARBAMAZEPINE; COBALT CHLORIDE; COTRIMOXAZOLE; LAMOTRIGINE; MELOXICAM; NICKEL SULFATE; PHENYLENEDIAMINE; PHENYTOIN; PIROXICAM; SALAZOSULFAPYRIDINE; STEROID; TENOXICAM; TOPIRAMATE; VALPROIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; DRESS SYNDROME; DRUG RECHALLENGE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; LIVER DISEASE; LYMPHOCYTE ACTIVATION; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; PATCH TEST; PATHOGENESIS; PATIENT SAFETY; SKIN MANIFESTATION;

ALLOPURINOL; AMOXICILLIN; ANTICONVULSANTS; DRUG HYPERSENSITIVITY; EOSINOPHILIA; EXANTHEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; PATCH TESTS; SULFASALAZINE; SYNDROME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 74949129204     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/j.1600-0536.2009.01659.x     Document Type: Article

References (38)

1. Shear N H, Spielberg S P. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 1988 : 82 : 1826 1832.
2. Schlienger R G, Shear N H. Antiepileptic drug hypersensitivity syndrome. Epilepsia 1998 : 39 : S3 S7.
3. Bocquet H, Bagot M, Roujeau J C. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996 : 15 : 250 257.
4. Roujeau J C, Stern R S. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994 : 331 : 1272 1285.
5. Chung W H, Hung S I, Chen Y T. Human leukocyte antigens and drug hypersensitivity. Curr Opin Allergy Clin Immunol 2007 : 7 : 317 323.
6. Phillips E J, Mallal S A. HLA and drug-induced toxicity. Curr Opin Mol Ther 2009 : 11 : 231 242.
7. Descamps V, Valance A, Edlinger C, Fillet A M, Grossin M, Lebrun-Vignes B, Belaich S, Crickx B. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001 : 137 : 301 304.
8. Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol 2004 : 140 : 183 188.
9. Knowles S R, Uetrecht J, Shear N H. Idiosyncratic drug reactions: the reactive metabolite syndromes. Lancet 2000 : 356 : 1587 1591.
10. Naisbitt DJ, Farrell J, Wong G et al. Characterization of drug-specific T cells in lamotrigine hypersensitivity. J Allergy Clin Immunol 2003 : 111 : 1393 1403.
11. Naisbitt D J, Britschgi M, Wong G et al. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol Pharmacol 2003 : 63 : 732 741.
12. Knowles S R, Shapiro L E, Shear N H. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Saf 1999 : 21 : 489 501.
13. Lerch M, Pichler W J. The immunological and clinical spectrum of delayed drug-induced exanthems. Curr Opin Allergy Clin Immunol 2004 : 4 : 411 419.
14. Pichler W, Yawalkar N, Schmid S, Helbling A. Pathogenesis of drug-induced exanthems. Allergy 2002 : 57 : 884 893.
15. Barbaud A, Reichert-Penetrat S, Tréchot P et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998 : 139 : 49 58. (Pubitemid 28338063)
16. Spielberg S. In vitro analysis of idiosyncratic drug reactions. Clin Biochem 1986 : 19 : 142 144.
17. Kano Y, Hirahara K, Mitsuyama Y et al. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption. Allergy 2007 : 62 : 1439 1444.
18. Wolkenstein P, Chosidow O, Fléchet M L, Robbiola O, Paul M, Dumé L, Revuz J, Roujeau J C. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996 : 35 : 234 236. (Pubitemid 26408155)
19. Barbaud A, Gonçalo M, Bruynzeel D, Bircher A. European Society of Contact Dermatitis. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001 : 45 : 321 328.
20. Kardaun S H, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici B B, Mockenhaupt M, Roujeau J C. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007 : 156 : 609 611.
21. Moore N, Biour M, Paux G, Loupi E, Begaud B, Boismare F, Royer R J. Adverse drug reaction monitoring: doing it the French way. Lancet 1985 : 2 : 1056 1058.
22. Bégaud B, Evreux J C, Jouglard J, Lagier G. Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie 1985 : 40 : 111 118.
23. Gonçalo M, Fernandes B, Oliveira H, Figueiredo A. Epicutaneous patch testing in drug eruptions. Contact Dermatitis 2000 : 42 : 52.
24. Barbaud A. Drug patch testing in systemic cutaneous drug allergy. Toxicology 2005 : 209 : 209 216.
25. Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 2005 : 152 : 968 974.
26. Vaillant L, Camenen I, Lorette G. Patch testing with carbamazepine: reinduction of an exfoliative dermatitis. Arch Dermatol 1989 : 125 : 299.
27. Houwerzijl J, DeGast G, Nater J. Patch tests in drug eruptions. Contact Dermatitis 1975 : 1 : 180 192.
28. Silva R, Machado A, Brandão M, Gonçalo S. Patch test diagnosis in carbamazepine erythroderma. Contact Dermatitis 1986 : 15 : 254 255.
29. Alanko K. Patch testing in cutaneous reactions caused by carbamazepine. Contact Dermatitis 1993 : 29 : 254 257.
30. Puig L, Nadal C, Fernández-Figueras M T, Alomar A. Carbamazepine induced drug rashes: diagnostic value of patch tests depends on clinico-pathologic presentation. Contact Dermatitis 1996 : 34 : 435 437.
31. Gonçalo M, Coelho S, Figueiredo A. Ascertaining patch test concentration in cutaneous adverse drug reactions to aminopenicillins and carbamazepine. J Invest Dermatol 2006 : 126 : S3 S67.
32. Galindo P A, Borja J, Gómez E et al. Anticonvulsant drug hypersensitivity. J Invest Allergol Clin Immunol 2002 : 12 : 299 304.
33. Lee A Y, Kim M J, Chey W Y, Choi J, Kim B G. Genetic polymorphism of cytochrome P450 2C9 in diphenylhydantoin-induced cutaneous adverse drug reactions. Eur J Clin Pharmacol 2004 : 60 : 155 159.
34. Monzón S, Garcés M M, Reichelt C, Lezaun A, Colás C. Positive patch test in hypersensitivity to lamotrigine. Contact Dermatitis 2002 : 47 : 361.
35. Schiavino D, Nucera E, Buonomo A et al. A case of type IV hypersensitivity to topiramate and carbamazepine. Contact Dermatitis 2005 : 52 : 161 162.
36. Klassen B D, Sadler R M. Induction of hypersensitivity to a previously tolerated antiepileptic drug by a second antiepileptic drug. Epilepsia 2001 : 42 : 433 435.
37. Vieira R, Gonçalo M, Figueiredo A. Testes epicutâneos ao alopurinol e oxipurinol em doentes com toxidermias ao alopurinol. Trab Soc Port Dermatol Venereol 2004 : 62 : 247 253.
38. Hamanaka H, Mizutani H, Nouchi N, Shimizu Y, Shimizu M. Allopurinol hypersensitivity syndrome: hypersensitivity to oxypurinol but not allopurinol. Clin Exp Dermatol 1998 : 23 : 32 34.